Analysts/Institutional Investor Meet/Con. Call Updates

Daur Ref: SEC/SE/2026-27 Date: August 03, 2026 India ltd. Corporate Relations Department Listing Department BSE Ltd. National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor Dalal Street, Plot No. C/1, G Block, Sandra Kurla Complex Mumbai- 400001 Sandra (E), Mumbai - 400051 BSE Scrip Code: 500096 NSE Scrip Symbol: DABUR Sub: Transcript of Investors' Conference Call for Dabur India Limited - Q1 FY 2026-27 Financial Results Dear Sir/Madam, Pursuant to the prov1s1ons of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Transcript of Investors' Conference Call organized on July 29, 2026, post declaration of Financial Results for the quarter ended on June 30, 2026. The aforementioned transcript is also available on the website of the Company at www.dabur.com. This is for your information and records. Thanking You, Yours faithfully, For Dabur India Limited (Ashok mar Jain) Group Company Secretary and Chief Compliance Officer Encl.: as above DABUR INDIA LIMITED, Punjabi Bhawan, 10, Rouse Avenue, New Delhi-110 002, Tel.: +91 11 71206000 Regd. Office: 8/3, Asaf Ali Road, New Delhi -110 002 (India) CIN: L24230DL1975PLC007908, Email: corpcomm@dabur.com, Website: www.dabur.com Dabur India Limited Q1 FY’27 Results Investors Conference Call July 29, 2026 MANAGEMENT : MR. MOHIT MALHOTRA-GLOBAL CHIEF EXECUTIVE OFFICER MR. HERJIT S. BHALLA-CHIEF EXECUTIVE OFFICER-INDIA BUSINESS MR. ANKUSH JAIN-CHIEF FINANCIAL OFFICER MR. RAHUL SARAWAGI-HEAD-INVESTOR RELATIONS AND M&A Page 1 of 9 Dabur India Limited July 29, 2026 Rahul Sarawagi: Good evening, ladies and gentlemen. On behalf of the management of Dabur India Limited, I welcome you to the earnings conference call pertaining to the results for the quarter ended 30th June, 2026. Present here with me are Mr. Mohit Malhotra, Global Chief Executive Officer; Mr. Ankush Jain, Chief Financial Officer; Mr. Herjit S. Bhalla, CEO, India Business. We'll start with an overview of the company's performance by Mr. Mohit Malhotra, and this will be followed by a Q&A session. I will now hand over to Mr. Mohit Malhotra. Thank you. Mohit Malhotra: Thank you Rahul. Good evening, ladies and gentlemen. We welcome you to Dabur India Limited's conference call pertaining to the results for the quarter ended 30th June '26. The Indian consumption environment remained stable during the quarter despite weather-related disruptions, inflationary headwinds and geopolitical disturbances. Rural demand continued to demonstrate momentum, outperforming urban markets. War-related disturbances in the Middle East impacted input cost trends and supply chain efficiency across our businesses, including India. Despite the challenging environment in the quarter, our international business delivered double-digit growth, supported by proactive market interventions and agile execution. Against this backdrop, Dabur delivered a strong start to the year. During quarter 1 FY27, our consolidated business grew by 10.6%, driven by broad-based growth across both India and international businesses. India FMCG business revenue grew by 9.5%, backed by volume growth of 5%. International business grew by 15.5% in INR terms. Within the domestic business, HPC portfolio continued its strong momentum, recording a 12.3% growth. Our hair care business, including hair oils and shampoos, registered strong double-digit growth. Hair Oil portfolio grew in high teens year-on- year with both perfumed and coconut oils growing in double digits. We outpaced category growth and gained 102 basis points in market share. The shampoo portfolio delivered strong double-digit growth during the quarter. During this period, Vatika launched Bio-Infusions range, India's first no-added salt shampoo range, reflecting our commitment to science-backed innovation and evolving consumer preferences. We continue to drive growth through a combination of premiumization, innovation and expanded participation in high-growth segments across both hair oils and shampoos. The Oral Care portfolio delivered near double-digit growth, led by strong momentum across the Red franchise, Meswak and the Dabur Herbal range. Lal Dant Manjan also posted a double-digit growth during the quarter. Consumer preferences for ayurvedic, herbal and natural oral care solutions continue to strengthen with herbal segment outperforming the non-herbal segment by 550 basis points. Supported by our strong portfolio in this category, we outperformed the overall toothpaste market growth and further strengthened our market share position. Skin Care portfolio registered a high single-digit growth driven by Gulabari franchise and OxyLife. The OxyLife de-tan range continues to gain traction among the consumers, reflecting the relevance of our premium skin care offerings. Page 2 of 9 Dabur India Limited July 29, 2026 The Home Care portfolio delivered mid-single-digit growth led by Odonil and Sanifresh. Odonil despite shortages in RM availability, posted a high single-digit growth during this quarter, aided by strong momentum in aerosols and zippers, translating into market share gain of around 80 bps. Our recently launched camphor cones and car fresheners have also witnessed encouraging consumer acceptance. Sanifresh continued the strong momentum, delivering a growth in high teens. In our Health Care portfolio, health supplements grew in low single digits. Honey performed very well with high single-digit growth, resulting in gain in market share of 150 bps. Premium variants like Sundarbans and Organic Honey witnessed good growth. Glucose portfolio was marginally impacted during the quarter on account of unseasonal rains at the beginning of the quarter and have since seen strong recovery in the second half of the quarter. In the Digestive portfolio, Pudin Hara franchise registered a double-digit growth. Recently launched Pudin Hara 5-in-1 fizz has also witnessed encouraging consumer response. Hajmola franchise registered a near double-digit growth, supported by packaging refresh across the portfolio. Isabgol registered a strong double-digit growth. Within OTC and Ethicals, Honitus registered a strong double-digit growth of 25%, driven by targeted media campaign reflecting and highlighting safety and efficacy. Health juices continued on a strong trajectory and grew in mid-20s. Our recently launched new age nutraceutical brand Siens grew 3x during the quarter. Our food and beverage portfolio registered a high single-digit growth. Despite unseasonal rains in the beginning of the quarter impacting April, our beverage portfolio made a strong comeback in May and June with mid- teens growth. Our premiumization strategy continued to deliver strong results with active juices growing by over 40% and coconut water registering a growth of over 70% during the quarter. We continue to outperform the category, gaining around 600 bps market share in active juices and 344 bps in coconut water. Our Foods business continued strong double-digit growth of around 30%. Badshah business registered a volume-led double-digit growth. Coming to international business, despite continued impact of war, we registered strong growth of 15.5% in INR terms. This was on back of around 9% growth in MENA region, 22% growth in U.K., European Union, 28% growth in Egypt, 27% growth in Turkey and 34% growth in Bangladesh. Coming to profitability now. Despite elevated inflation across several input categories and continued cost pressures in most international markets, we delivered a healthy margin performance through a combination of portfolio premiumization, productivity improvement initiatives and disciplined cost management. As a result, operating margin grew by 11% and profit after tax increased by 15%, both ahead of the top line, reflecting the strength of our brand portfolio, execution capabilities and resilient business model. Looking ahead, while geopolitical developments in the Middl [Showing first 8,000 characters — download PDF for full document]